← Back to Patent Explorer
US4315002A Expired / Lapsed US ⏱️ 0.0 years remaining

Solid pharmaceutical or diagnostic agent containing dextran and its preparation

Assignee: BASF SE
•
Filing: 1980-05-30
•
Granted: 1982-02-09
•
Expires: 2000-05-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for the preparation of a solid pharmaceutical or diagnostic composition in which the active substance and dextran are dissolved in water, the solution is placed in a mold and is thereafter lyophilized to form a solid abrasion-resistant tablet which can further be compressed to reduce its rate of disintegration in water. The invention is also directed to the pharmaceutical or diagnostic agent produced by this process.

Inventors

  • 👤 Robert Maurer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 07:54
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/19; A61K47/00; A61K47/30; A61K47/36; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 49 words
A process for the preparation of a solid composition containing a pharmaceutical or diagnostic agent which comprises: dissolving the pharmaceutical or diagnostic agent and dextran in water, placing the solution in a mold, and thereafter lyophilizing the solution to form a solid abrasion-resistant tablet of said agent and dextran.
Claim 2
Dependent Claim 49 words
A process for the preparation of a solid composition containing a pharmaceutical or diagnostic agent which comprises: dissolving the pharmaceutical or diagnostic agent and dextran in water, placing the solution in a mold, and thereafter lyophilizing the solution to form a solid abrasion-resistant tablet of said agent and dextran.
Claim 3
Dependent Claim 20 words
The process of claim 1, wherein the solid abrasion-resistant tablet is compressed to reduce its rate of disintegration in water.
Claim 4
Dependent Claim 16 words
The process of claim 1 or 2, wherein the agent is an enzyme or an antibiotic.
Claim 5
Dependent Claim 26 words
The process of claim 1 or 2, wherein the agent is selected from the group consisting of pencillins, streptomycins, tetracyclins, fibrinogenase, aminoacid-oxidase, streptokinase, urokinase and caseinase.
Claim 6
Dependent Claim 9 words
The composition produced by the process of claim 1.
Claim 7
Dependent Claim 9 words
The composition produced by the process of claim 2.
Claim 8
Dependent Claim 30 words
The composition produced by the process of claim 4, wherein the agent is present in an amount from 10 to 50% by weight based on the weight of the composition.

References Cited (Backward Citations)

US3655838A Cited
US4134943A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-02-08 1985-08-10 1986-02-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-02-08 1989-08-10 1990-02-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-02-08 1993-08-10 1994-02-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag